InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC

IRWD Clue Score47
United States Fiscal year ends December CIK 0001446847 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Thomas A MCCOURT
5 Jan 2023
Chief Executive Officer
Sold after exercise
110,962
$12.07
$1.34M
Jason Rickard
9 Aug 2022
SVP, Chief Operating Officer
Sold after exercise
18,041
$11.75
$211.98K
Mark G Currie
7 Jun 2022
Director
Sold after exercise
190,383
$12.01
$2.29M
Kelly MacDonald
4 Dec 2020
Chief Accounting Officer
Sold after exercise
5,639
$12.50
$70.49K
Kelly MacDonald
11 Nov 2020
Chief Accounting Officer
Sold after exercise
3,561
$11.75
$41.84K
Halley E Gilbert
31 Jan 2020
Chief Admin Officer & SVP
Sold after exercise
60,000
$12.05
$723.00K
Thomas A MCCOURT
24 Jan 2020
President
Sold after exercise
20,000
$12.71
$254.20K
Mark G Currie
23 Jan 2020
Director
Sold after exercise
60,000
$12.59
$755.40K
Mark G Currie
16 Jan 2020
Director
Sold after exercise
8,888
$12.80
$113.77K
Thomas A MCCOURT
30 Aug 2019
President
Sold after exercise
220,000
$9.24
$2.03M
Halley E Gilbert
26 Jul 2019
Chief Admin Officer & SVP
Sold after exercise
20,000
$10.00
$200.00K
Showing 250 of 315 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 454
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 32
Sales at will 259
Transactions with no price 0
Shares from compensation/vesting 25,980,489
Sales filed before the plan box existed 210
History held since 4 Feb 2010